Cargando…
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk
Breast cancer is a complex disease which is provoked by a multitude of exogenous and endogenous factors including genetic variations. Recent genome-wide association studies identified a set of more than 18 novel low penetrant susceptibility loci, however, a limitation of this powerful approach is th...
Autor principal: | Justenhoven, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508624/ https://www.ncbi.nlm.nih.gov/pubmed/23226154 http://dx.doi.org/10.3389/fgene.2012.00258 |
Ejemplares similares
-
Functional Polymorphisms in Xenobiotic Metabolizing Enzymes and Their Impact on the Therapy of Breast Cancer
por: Vianna-Jorge, Rosane, et al.
Publicado: (2013) -
Polymorphisms in Phase I and Phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case–control study in Inuit women
por: Ghisari, Mandana, et al.
Publicado: (2014) -
The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients
por: Rezaei, Mitra, et al.
Publicado: (2022) -
Effect of the Angiotensin-Converting Enzyme (ACE) (I/D) Polymorphism in COVID-19 Patients and Their Healthy Contacts
por: Gupta, Prishni, et al.
Publicado: (2023) -
Comprehensive analysis of liquid-liquid phase separation-related genes in prediction of breast cancer prognosis
por: Yu-Qing, Huang, et al.
Publicado: (2022)